vs
NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP（NRUC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP的1.3倍（$69.8M vs $53.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 41.6%，领先342.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -52.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -1.5%）
美国国家农村公用事业合作金融公司（CFC）是一家由成员所有的非盈利合作社，为美国农村电力合作网络提供金融产品。该公司成立于1969年，创立初衷是从资本市场筹集资金，补充美国农业部农村公用事业局面向电力合作社的贷款项目。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NRUC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$53.8M
营收增速更快
RIGL
高出73.8%
-52.7%
净利率更高
RIGL
高出342.5%
41.6%
两年增速更快
RIGL
近两年复合增速
-1.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.8M | $69.8M |
| 净利润 | $22.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 41.6% | 384.0% |
| 营收同比 | -52.7% | 21.2% |
| 净利润同比 | -74.0% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRUCRIGL
| Q1 26 | $53.8M | — | ||
| Q4 25 | $59.0M | $69.8M | ||
| Q3 25 | $47.3M | $69.5M | ||
| Q2 25 | $66.9M | $101.7M | ||
| Q1 25 | $113.7M | $53.3M | ||
| Q4 24 | $182.0M | $57.6M | ||
| Q3 24 | $61.7M | $55.3M | ||
| Q2 24 | — | $36.8M |
净利润NRUCRIGL
| Q1 26 | $22.4M | — | ||
| Q4 25 | $19.6M | $268.1M | ||
| Q3 25 | $4.8M | $27.9M | ||
| Q2 25 | $73.1M | $59.6M | ||
| Q1 25 | $86.0M | $11.4M | ||
| Q4 24 | $144.4M | $14.3M | ||
| Q3 24 | $-163.8M | $12.4M | ||
| Q2 24 | — | $-1.0M |
毛利率NRUCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率NRUCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% |
净利率NRUCRIGL
| Q1 26 | 41.6% | — | ||
| Q4 25 | 33.2% | 384.0% | ||
| Q3 25 | 10.1% | 40.2% | ||
| Q2 25 | 109.3% | 58.6% | ||
| Q1 25 | 75.6% | 21.5% | ||
| Q4 24 | 79.4% | 24.9% | ||
| Q3 24 | -265.7% | 22.5% | ||
| Q2 24 | — | -2.8% |
每股收益（稀释后）NRUCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $240.7M | $155.0M |
| 总债务越低越好 | $28.9B | $52.5M |
| 股东权益账面价值 | $3.1B | $391.5M |
| 总资产 | $39.9B | $513.6M |
| 负债/权益比越低杠杆越低 | 9.40× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NRUCRIGL
| Q1 26 | $240.7M | — | ||
| Q4 25 | $304.5M | $155.0M | ||
| Q3 25 | $257.1M | $137.1M | ||
| Q2 25 | $134.7M | $108.4M | ||
| Q1 25 | $245.4M | $77.1M | ||
| Q4 24 | $347.1M | $77.3M | ||
| Q3 24 | $264.7M | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务NRUCRIGL
| Q1 26 | $28.9B | — | ||
| Q4 25 | $27.3B | $52.5M | ||
| Q3 25 | $27.9B | $60.0M | ||
| Q2 25 | $27.2B | $60.0M | ||
| Q1 25 | $27.5B | $60.0M | ||
| Q4 24 | $26.7B | $60.0M | ||
| Q3 24 | $26.3B | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益NRUCRIGL
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.1B | $391.5M | ||
| Q3 25 | $3.0B | $117.6M | ||
| Q2 25 | $3.1B | $81.9M | ||
| Q1 25 | $3.0B | $18.6M | ||
| Q4 24 | $2.9B | $3.3M | ||
| Q3 24 | $2.8B | $-14.6M | ||
| Q2 24 | — | $-29.9M |
总资产NRUCRIGL
| Q1 26 | $39.9B | — | ||
| Q4 25 | $39.1B | $513.6M | ||
| Q3 25 | $38.8B | $242.5M | ||
| Q2 25 | $38.3B | $206.7M | ||
| Q1 25 | $37.8B | $176.0M | ||
| Q4 24 | $37.1B | $164.0M | ||
| Q3 24 | $36.5B | $139.4M | ||
| Q2 24 | — | $128.4M |
负债/权益比NRUCRIGL
| Q1 26 | 9.40× | — | ||
| Q4 25 | 8.95× | 0.13× | ||
| Q3 25 | 9.21× | 0.51× | ||
| Q2 25 | 8.81× | 0.73× | ||
| Q1 25 | 9.15× | 3.23× | ||
| Q4 24 | 9.14× | 18.25× | ||
| Q3 24 | 9.44× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $105.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $105.1M | — |
| 自由现金流率自由现金流/营收 | 195.2% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 4.72× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $428.2M | — |
8季度趋势，按日历期对齐
经营现金流NRUCRIGL
| Q1 26 | $105.6M | — | ||
| Q4 25 | $38.9M | $22.0M | ||
| Q3 25 | $82.3M | $24.0M | ||
| Q2 25 | $207.5M | $30.5M | ||
| Q1 25 | $150.3M | $-893.0K | ||
| Q4 24 | $63.8M | $14.5M | ||
| Q3 24 | $36.7M | $21.7M | ||
| Q2 24 | — | $302.0K |
自由现金流NRUCRIGL
| Q1 26 | $105.1M | — | ||
| Q4 25 | $38.3M | — | ||
| Q3 25 | $82.0M | — | ||
| Q2 25 | $202.8M | — | ||
| Q1 25 | $149.0M | — | ||
| Q4 24 | $62.7M | — | ||
| Q3 24 | $35.4M | — | ||
| Q2 24 | — | — |
自由现金流率NRUCRIGL
| Q1 26 | 195.2% | — | ||
| Q4 25 | 64.9% | — | ||
| Q3 25 | 173.4% | — | ||
| Q2 25 | 303.1% | — | ||
| Q1 25 | 131.0% | — | ||
| Q4 24 | 34.5% | — | ||
| Q3 24 | 57.5% | — | ||
| Q2 24 | — | — |
资本支出强度NRUCRIGL
| Q1 26 | 0.9% | — | ||
| Q4 25 | 1.1% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | — | — |
现金转化率NRUCRIGL
| Q1 26 | 4.72× | — | ||
| Q4 25 | 1.99× | 0.08× | ||
| Q3 25 | 17.27× | 0.86× | ||
| Q2 25 | 2.84× | 0.51× | ||
| Q1 25 | 1.75× | -0.08× | ||
| Q4 24 | 0.44× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
